Format

Send to

Choose Destination
Curr Diab Rep. 2008 Jun;8(3):179-84.

Beta-cell failure in type 2 diabetes mellitus.

Author information

1
Department of Endocrinology and Metabolism, Section of Diabetes and Metabolic Diseases, University of Pisa, Ospedale Cisanello, Via Paradisa, 2, 56124 Pisa, Italy.

Abstract

Diabetes mellitus has been defined as a "group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both" and encompasses a wide range of heterogeneous conditions. Common type 2 diabetes mellitus (T2DM) results from a combination of genetic and acquired factors. However, lifestyle factors, particularly overeating and physical inactivity, are the major clinical determinants of T2DM. Insulin resistance is a common feature of T2DM, but it is unlikely to cause T2DM unless progressive loss of beta-cell function develops. Significant reduction in beta-cell function is already present at the time of T2DM diagnosis, and it continuously declines irrespective of treatment. As such, the progressive loss of beta-cell function dictates the rate of worsened glycemic control. Development of progressive deterioration accelerates via gluco- and lipotoxicity, loss of beta-cell function, and shrinkage of beta-cell mass. Understanding the causes for beta-cell failure is therefore of capital importance to develop new and more effective therapeutic strategies.

PMID:
18625113
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center